Radiolabeling of umbilical cord-derived mesenchymal stem cells for in vivo tracking

Cancer Biotherapy and Radiopharmaceuticals

Volumn 27, Issue 9, 2012, Pages 614-619

  Mukherjee, Archana ^a   Tipnis, Shabari ^b   Sarma, Haladhar Dev ^a   Ravindran, Geeta ^b   Samuel, Grace ^a   Viswanathan, Chandra ^b   Venkatesh, Meera ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b RELIANCE LIFE SCIENCES PVT LTD   (India)

Author keywords

51Cr labeled stem cells; Radiolabeled stem cells; Umbilical cord mesenchymal stem cells (UCMSC)

Indexed keywords

CHROMIUM 51;

ARTICLE; CELL FATE; CELL ISOLATION; CELL TRACKING; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; ISOTOPE LABELING; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CHROMIUM RADIOISOTOPES; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FETAL BLOOD; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR;

EID: 84868286832     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.1146     Document Type: Article

References (14)

1. Mimealt M, Hauke R, Batra SK. Stem cells: A revolution in therapeutics recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies: State of the art. Clin Pharmacol Ther 2007; 82:252.
2. Bajadal S, Mazakova I, Richardson JB, et al. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008;2:169.
3. Gupta R, Losordo DW. Challenges in the translation of cardiovascular cell therapy. J Nucl Med 2010;51:122S
4. Lucignani G, Rodriguez Porcel M. In vivo imaging of stem cell therapy: New developments and future challenges. Eur J Nucl Med Mol Imaging 2011;38:400.
5. Wu JC, Abraham MR, Kraitchman DL. Current perspectives on imaging cardiac stem cell therapy. J Nucl Med 2010; 51:128S.
6. Zhang SJ, Wu JC. Comparison of imaging techniques for tracking cardiac stem cell therapy. J Nucl Med 2007;48: 1916.
7. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow derived mesenchymal stem cells to the infracted myocardium: Feasibility, cell migration, and body distribution. Circulation 2003;108:863.
8. Fengi M, Zhu H, Zhu Z, et al. Serial 18F FDG PET demonstrates benefit of human mesenchymal stem cells in treatment of intracerebral Hematoma: A translational study in a primate model. J Nucl Med 2011;52:90.
9. Bindslev L, Haack-Sorensen M, Bisgaard K. Labelling of human mesenchymal stem cells with indium111 for SPECT imaging: Effect on cell proliferation and differentiation. Eur J Nucl Med Mol Imaging 2006;33:1171.
10. Tipnis S, Viswanathan C, Sen Majumdar A. Immunosuppressive properties of human umbilical cord derived mesenchymal stemcells: Role of B7H1 and IDO. Immunol Cell Biol 2010;88:795.
11. Shetty P, Cooper K, Viswanathan C. Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood and bone marrow derived mesenchymal stem cells. Asian J Transf Sci 2010;4:1
12. McAfee JG, Thakur ML. Survey of Radioactive agents for Invitro labeling of phagocytic leukocytes: 1 Soluble Agents. J Nucl Med 1976;17:480.
13. Gobunty AH, Robinson RO, Barth RF. Organ distribution of 99mTc and 51Cr labeled autologous peripheral blood lymphocytes in rabbits. J Nucl Med 1977;18:141.
14. Barth RF, Singla O. Organ distribution of 99mTc and 51Cr labeled thymocytes. J Nucl Med 1975;16:633.